Look at this place, the Sackler Wing at the Metropolitan Museum of Art in New York. Sunlight streams through the massive glass curtain wall, illuminating the Temple of Dendur. This is the crystallization of human civilization, a sanctuary of art, history, and beauty. At Harvard, Yale, Oxford, and the Louvre, the Sackler name is inscribed on the walls of humanity's most prestigious academic and artistic institutions. This is a family that represented generosity, philanthropy, and refined taste.

Yet, in the same country, in Lee County, Virginia, it's another world. Here, the Sackler name is synonymous with plague. High school cheerleaders sneak into bathrooms to do drugs before prom. Babies are born struggling with withdrawal symptoms. A rural doctor despairingly discovers that the children he delivered are dying one by one from drug overdoses as adults.

Connecting these two extreme worlds is the tiny pill, OxyContin. On one side, billions of dollars in art donations; on the other, the worst drug abuse crisis in American history, having caused hundreds of thousands of deaths. This sounds like a devil's bargain, doesn't it? Today, the question we want to answer is: how and why did a family considered American aristocracy wage a 20-year, lucrative chemical war against its own country?

This is a story of deception, greed, and how one family systematically packaged lies into a "miracle cure." This is the story of an empire of pain.

To understand Purdue Pharma and OxyContin, you must first understand one person—not Raymond or Mortimer, the two brothers who later profited from OxyContin. We need to talk about their elder brother, Arthur Sackler. Arthur was the godfather of the Sackler family, the Edison of modern pharmaceutical marketing. He was a genius, a true Renaissance man, simultaneously a doctor, psychiatrist, art collector, and an advertising madman.

As early as the 1940s, Arthur revolutionized the pharmaceutical industry. Before him, drug advertising was very restrained. Arthur, however, transformed selling medicine into selling a lifestyle. His most classic move was with Roche's Valium. Under Arthur's marketing, Valium was no longer just a simple tranquilizer; it became "mother's little helper." He even helped invent a new medical concept called "nervous tension," then packaged Valium as the perfect antidote for this new ailment.

But central to Arthur Sackler was his obsession with control and secrecy. According to investigative journalists, Arthur built a vast and clandestine business network. He operated the largest pharmaceutical advertising agency, and simultaneously controlled a series of seemingly independent medical journals and newsletters, such as the Medical Tribune. This publication was distributed free to 160,000 doctors nationwide. One can guess what these "independent" medical newspapers would publish: research articles, of course, extolling his clients' drugs. He even disguised advertisements for client drugs, such as Pfizer's antibiotics, as doctors' business cards and letters of recommendation. Later, investigative journalists discovered that these so-called doctors didn't even exist.

A deeper secret is that in the 1950s, the FDA experienced a huge corruption scandal. Henry Welch, head of the antibiotic division, was found to be working for "independent medical journals" and collecting enormous royalties from them. Investigations revealed that behind these journals were Arthur Sackler's hidden companies. So you see, decades before OxyContin appeared, the Sackler family's DNA was already set: first, drugs were no longer medicine but commodities for which demand could be created; second, control the narrative by funding doctors and controlling journals to make marketing appear scientific; third, absolute secrecy, establishing complex corporate networks to separate the family name from dirty business practices.

Arthur died in 1987, but he left his two brothers not just the inconspicuous small company Purdue Frederick, but also this complete and proven highly successful imperial methodology.

Before OxyContin emerged, the American medical community was shrouded in a fear known as opioid-phobia. This fear had historical roots: the American Civil War spawned the first generation of morphine addicts, known as "soldier's disease"; by the early 20th century, the Harrison Act led to doctors facing imprisonment for prescribing narcotics. What was the result? Doctors preferred to let patients suffer in pain rather than prescribe painkillers, especially in late-stage cancer wards, where human tragedies unfolded repeatedly.

The medical standard at the time was called PRN (Pro re nata: Latin for "as needed"). Sounds reasonable, right? But in practice, it meant patients had to wait until their pain was unbearable and they started screaming before they could request a morphine injection. And nurses and doctors, fearing addiction, would deliberately delay administering the medication. This led to a terrible "rollercoaster effect": patients cycled between extreme pain and brief numbness. Worse still, when pain peaked, larger doses of morphine were needed to suppress it, which ironically made patients more prone to mental confusion and coma.

This was the starting point of the hospice movement. Pioneers like Cecily Saunders began advocating that the end of life should be dignified and pain-free. New York's Memorial Sloan Kettering Cancer Center became the vanguard of this movement. They discovered that if morphine was administered on a schedule, maintaining a stable level in the blood, patients would not experience that rollercoaster of pain. They could remain lucid at all times, even communicating normally with family in their final stages of life. This was a huge medical advance, proving that in specific circumstances, large doses of opioids could be safely used.

In 1986, Portenoy and his mentor, Catherine Foley, published a far-reaching paper. They tracked 38 non-cancer patients and concluded that long-term opioid use was safe and effective for them. A sample size of 38 is pitifully small, but in an era eager for liberation of thought, this article was like a signal flare. Portenoy became the standard-bearer of the pain revolution, embarking on national speaking tours, denouncing the medical community's opioid-phobia as an outdated, inhumane prejudice.

To support his revolution, Portenoy and his followers repeatedly used three key pieces of evidence, known as the "Holy Trinity" of the pain movement: 1. **Boston University study**: Cited as only 4 cases of addiction among 11,882 hospitalized patients. This less-than-1% figure became the core of all subsequent marketing. 2. **Diamond Clinic study**: A study of 2,369 headache patients, reportedly found only 3 cases of addiction. 3. **Burn center study**: Also showed extremely low addiction rates.

In the face of this "ironclad evidence," the old defenses collapsed. A new medical consensus began to form, generously funded by pharmaceutical companies: pain was no longer merely a symptom; it was a disease in itself that needed to be eradicated. Doctors' ethical standards were reshaped: it was immoral to let patients suffer pain, and doctors who dared not prescribe medication were outdated and callous. A humanitarian "crusade" was fully prepared; it now lacked only one thing—a perfect weapon.

At this point, Arthur Sackler's two brothers, Raymond and Mortimer, entered the scene with their Purdue Pharma company. They were not newcomers; in the 1980s, they had already made a fortune with MS Contin, a sustained-release morphine for cancer pain. Now, they saw the non-cancer pain revolution ignited by Portenoy—a blue ocean hundreds of times larger than the cancer market. They needed a better weapon. The word "morphine" had too bad a reputation, evoking death and war. They needed something that seemed gentler and more modern.

They chose OxyContin. This was the active ingredient in Tylenol and Percocet, but Purdue purified it. The true genius lay in Contin, Purdue's patented controlled-release system. The theory was this: ordinary painkillers have a rapid onset, bringing pleasure and a "high," but a quick decline leads to pain and craving, which is the root of addiction. OxyContin, however, would steadily release its potency over 12 hours, with no peaks and no valleys. Therefore, it provided pure pain relief, theoretically eliminating the pleasure of addiction. This was nothing short of the perfect "Holy Grail"—an opioid that could powerfully relieve pain without causing addiction.

By 1995, Purdue Pharma submitted its application for market approval to the FDA. They successfully persuaded the FDA, which not only approved it but also granted an unprecedented and decisive label claim: on OxyContin's package insert, the FDA allowed Purdue to print the sentence, "Delayed absorption, as provided by OxyContin tablets, is believed to reduce the abuse liability of the drug." This single sentence became Purdue Pharma's ultimate weapon.

Investigative journalists revealed in their book that an FDA official named Diane, while reviewing the document, had annotated it with "This sounds like BS," but her objection was overruled. The FDA reviewer responsible for approving this label was named Curtis Wright IV. Shortly after approving OxyContin, Dr. Wright resigned from the FDA. In 1998, he joined Purdue Pharma, with a first-year compensation package of up to $379,000.

Now the script was complete: a humanitarian medical revolution, a scientific myth of less than 1% addiction, a perfect non-addictive weapon, and official endorsement from the highest regulatory body of the U.S. government. Arthur Sackler's ghost must have been smiling; his brothers were about to unleash his sophisticated marketing machine to sell this story to all of America.

When OxyContin launched in 1996, Purdue Pharma unleashed the largest marketing blitz for a single drug in American history. Their target was not cancer specialists or pain experts, but the most unprepared and least trained group in pain management—general practitioners, family doctors, and rural doctors. Arthur Sackler's marketing playbook was perfectly replicated and amplified a hundredfold.

**First tactic: Human wave tactics and financial incentives.** Purdue's sales team doubled from over 300 to over 600 people. They had the most generous bonus system in history. According to investigative journalists, sales representatives' bonuses were not based on how many prescriptions they sold, but on the total value of the drugs they sold. This meant they had a strong incentive to persuade doctors to prescribe the highest-dose, most expensive pills.

**Second tactic: Precise data hacking.** Purdue purchased massive amounts of doctor prescription data from IMS Health. They built a huge database that could precisely identify which doctors most frequently prescribed painkillers—they called this the "Combined Opportunity Report," identifying which doctors were "high-volume prescribers." Sales representatives then used this data to visit these doctors with cruise missile-like precision.

**Third tactic: Brainwashing disguised as education.** Purdue sponsored thousands of pain management seminars. They flew over 2,000 doctors to luxury resorts in Arizona, Florida, and California for all-inclusive lavish weekends. At these "educational conferences," opinion leaders recruited by Purdue—doctors who had been bought, such as Dr. Susan Bertrand (who charged up to $3,000 per lecture)—would repeatedly instill the official narrative: pain is the fifth vital sign, opioid-phobia is immoral, and OxyContin's addiction rate is less than 1%.

Most astonishingly, Purdue launched a plethora of branded merchandise: bucket hats, teddy bears, even swing dance CDs. This was the essence of Arthur Sackler: normalization. They packaged a powerful narcotic, comparable in potency to heroin, to appear as safe, commonplace, and even fashionable as an antibiotic or blood pressure medication. They subconsciously disarmed doctors—this was no longer a devil locked in a safe, but a gift you could give to your patients.

This marketing blitz achieved catastrophic success in places like the Appalachian Mountains. This is Lee County, Virginia, a poverty-stricken area sustained by coal mining and rife with work injuries. This was "ground zero" for the OxyContin crisis.

We need to meet another protagonist in this story—Dr. Art Van Zee. Dr. Van Zee was an idealist; he could have lived a comfortable life in a big city, but he chose to run a clinic for 25 years in St. Charles, one of the poorest towns in Appalachia. He treated generations of people here, from birth to death; his sense of responsibility to this community was ingrained.

Starting in 1999, Dr. Van Zee noticed something was amiss. Late one night in January 2000, Dr. Van Zee received an emergency call: a young girl had overdosed and was on a ventilator. When he arrived at the hospital and opened her medical chart, he was stunned—he knew this girl. 21 years ago, he had personally given her immunizations; he had watched her grow up. Now, she was on the brink of death because of OxyContin.

This was not an isolated case. The world around Van Zee began to collapse. He heard from local pharmacist Greg Stewart that the drug was rampant on the streets. He conducted an anonymous survey at his local high school, and the results horrified him: 28% of eleventh-grade students admitted to having tried OxyContin.

The girl, Lindsey Myers, was a cheerleader at Lee County High School. She came from a well-off family, drove a brand-new Jeep, and was the town's golden girl. At sixteen, she and a friend first tried OxyContin in a car. She watched her friend moisten the pill in her mouth, dry it with a T-shirt, crush it between banknotes, and then snort it. She quickly became addicted. At first, she only had leg pain, which was the onset of withdrawal symptoms. Her mother, Jane, thought her daughter was just tired and massaged her in the middle of the night. Soon, Lindsey began stealing money from home; she found cash hidden by her parents in a bedroom safe, disguised as shaving cream cans. She spent $300 a day on drugs.

On her high school graduation night, a moment that should have been one of the most glorious in her life, she was experiencing painful withdrawal. When halftime approached and it was time to go on stage to receive flowers from her parents, she slipped into the tunnel beneath the stadium to meet her drug dealer boyfriend. She snorted the 40mg OxyContin she had just acquired, wiped away the nosebleed, and ran back onto the field, forcing a cheerleader's signature smile onto her face. Dr. Van Zee realized he was facing not the downfall of a few bad kids, but a plague sweeping through the entire community.

It is only when disaster strikes that you truly see a person's true colors. Now we will compare two initial reactions. First, Dr. Van Zee's reaction: he was a doctor and a scholar, and he began collecting data. He discovered that OxyContin was spreading in a strange way, not from big cities to rural areas, but like a virus, simultaneously erupting in remote rural hotspots in Maine, Virginia, Ohio, and Pennsylvania. He thought there must be a mistake somewhere.

In 2000, he wrote a letter to David Haddox, Purdue Pharma's medical director. The tone of the letter was very humble, sharing his concerns like a fellow doctor: "Our community is facing huge problems, and I look forward to further dialogue with you." He naively believed that Purdue's executives—those well-educated doctors and scientists—were simply unaware, and that if they knew the truth, they would be shocked and take immediate action.

Now let's look at Purdue Pharma's initial reaction. As early as early 2000, Jay McCloskey, the U.S. Attorney for Maine, noticed a surge in OxyContin abuse and crime rates. He issued a warning to doctors across the state, the first official warning nationwide. What was Purdue's internal response? According to an internal memo disclosed by investigative journalists, public relations director Robin Hogan scribbled, "We need a strategy to control this situation." Their first reaction was not "how do we solve this health crisis," but "how do we control this public relations crisis."

Purdue's PR machine immediately sprang into action. They hired top crisis management firms, such as Nichols Dezenhall, a company known for defending the embattled breast implant and lead paint industries. Their strategy was Arthur Sackler's classic playbook: 1. **Blame the victims**: They portrayed the OxyContin crisis as a unique problem of the Appalachian region. They claimed the people there were inherently poor, poorly educated, and had a tradition of drug abuse. This was a problem of criminals, not the drug. 2. **Invent new terms**: They called OxyContin "the drug of the day," implying that the media always sensationalizes a new drug, and it would blow over soon. 3. **Shift focus**: They created misleading charts showing more emergency room visits caused by hydrocodone-containing drugs, but this was solely because those drugs were prescribed three times more often than OxyContin. 4. **Play the victim**: They claimed that the true victims were the silent, legitimate pain patients, and that the media's hysteria was depriving them of access to a "miracle drug."

A rural doctor was trying to save lives, while a pharmaceutical empire was trying to save its financial reports. This war was unequal from the start.

By October 2000, Dr. Van Zee finally got his meeting with Purdue executives. David Haddox flew to Virginia. Haddox himself was the perfect embodiment of Purdue's official narrative; he was a professionally trained pain and addiction expert. In fact, he was the one who coined the term "pseudoaddiction." What did this term mean? According to Haddox's 1989 paper, based on a single patient case, if a patient exhibited all the signs of addiction—such as drug craving, deceiving doctors to obtain prescriptions from multiple hospitals—it didn't mean they were addicted. No, it simply meant you weren't giving them enough medication; they were acting like an addict because their pain wasn't adequately managed. Do you understand the diabolical nature of this theory? It redefined all red flags—clear signals of addiction—as green lights—demands for increased dosage.

At a meeting in Richlands, Dr. Van Zee directly challenged Haddox: "Why are you sending doctors swing dance CDs and plush toys with the OxyContin logo? Is this appropriate?" Haddox arrogantly replied, "How is this any different from other pharmaceutical companies?" Dr. Van Zee responded with the classic line: "Sir, people don't rob their neighbors for blood pressure medication." Haddox was speechless, made an excuse about having a long way to go, and turned to leave.

Dr. Van Zee did not give up. In November 2000, he met with Haddox again. This time, he brought a detailed list with eight suggestions. It was an extremely rational, constructive list. He did not demand immediate removal of the drug from the market; he requested: 1. **Issue a red alert letter**: Immediately warn all doctors nationwide that OxyContin had been found to have serious abuse problems, being crushed and injected. 2. **Stop marketing**: Immediately cease advertising OxyContin for chronic non-cancer pain. 3. **Investigate data**: Purdue should investigate why their sales and marketing efforts were disproportionately high in abuse hotspots like Appalachia. 4. **Immediately replace the original OxyContin with a formula containing naloxone**: This point was crucial. Naloxone is an opioid antagonist; if taken orally, it has no effect. But if an addict tried to crush, inject, or snort the pill, naloxone would be activated, blocking all euphoria. This technology was not new; as early as the 1980s, another painkiller, due to abuse, was mandated to include naloxone and renamed Talwin NX, and the abuse problem instantly disappeared. Dr. Van Zee's message was: you have a way to stop all this; do it immediately.

Haddox politely accepted the list, saying he would pass it on. After that, Dr. Van Zee never received any substantial reply.

Purdue Pharma ignored Dr. Van Zee's suggestions. Their public stance consistently was: "We were shocked and surprised by the 2000 Maine alert; we are innocent, and we are also victims." This was an outright lie. Years later, when federal prosecutors finally pried open Purdue's safe and obtained thousands of internal emails and memos, the truth was revealed.

The truth was, Purdue executives knew from day one that OxyContin would be abused, and they had been actively covering up this fact. Before OxyContin's launch, Purdue's flagship product, MS Contin, was already being abused in Australia and the United States. Addicts called them "purple crush," and they had long mastered the method of crushing and injecting extended-release pills. Purdue internally knew well that their controlled-release system could be circumvented.

Just one year after OxyContin's launch, according to court documents obtained by investigative journalists, a sales representative in Washington State reported internally in 1997 that a local Dr. Norton complained his patients were chewing OxyContin for euphoria. In 1998, the Canadian Medical Association Journal published a study finding that sustained-release morphine was highly sought after on Vancouver streets. More importantly, the accompanying editorial explicitly named OxyContin, which had just launched in Canada, warning that "we can expect OxyContin to also flow into the black market." This editorial was sent directly to Purdue headquarters.

In March 1998, after seeing these reports, Purdue's chief counsel, Howard Udell, sent a legal memo titled "MS Contin Abuse" to Sackler family members. They discussed it, but they did nothing. Instead, in 1998, Purdue Pharma's sales surged. Far from warning doctors, they intensified efforts, pushing sales representatives to distribute the outdated 1993 Daniel Brookoff study, which claimed addicts disliked extended-release pills. They knew there was a tiger in the mountains but told everyone the tiger didn't exist.

If 1998 was a warning, then 1999 was the year Purdue's internal alarms went off. This was a full year before they claimed to have first learned of the abuse problem. Chief Counsel Howard Udell admitted in an internal email: "We have indeed found information on the internet regarding the abuse of our opioid products."

In January 1999, an Ohio sales representative reported by phone: "Today, doctors only want to discuss the new street value of OxyContin." In February 1999, Dr. Frank Fisher's pharmaceutical facility in Redding, California, was raided by police; it was one of the first clinics nationwide shut down for over-prescribing OxyContin. Purdue internally received the alert. In April of the same year, the Weirton Daily Times in West Virginia reported that heroin and OxyContin were flooding the streets. Two Purdue sales representatives immediately rushed to the newspaper office to obtain a copy of the article. In August of the same year, Pennsylvania officials warned doctors that addicts had found ways to circumvent oral administration. Purdue's sales representatives relayed this alert back to headquarters.

Yes, all these warnings resulted not in a retraction, but in even more shameless marketing strategies. In 1999, Purdue's marketing manager, Mark Alfonso, sent a training memo to his team, instructing them on how to address doctors' concerns. The memo stated: if a doctor says they are crushing and injecting it, as a sales representative, you should respond: "How many of your patients come in with needle marks?" The doctor will reply "None," then you say "So what's the problem?" If a doctor says the police are arresting people for using OxyContin, you should reply "Great, that means the police are doing what they should be doing. If patients and abusers reconfigure the drug after leaving your office, that is not your responsibility."

This is the truth: they knew all along. They knew the drug was being crushed, they knew it was being injected, they knew it was rampant on the streets, and they knew doctors were concerned. Their strategy was not to warn doctors, but to teach sales representatives how to alleviate doctors' concerns, how to make doctors feel "that's not my responsibility," and thus continue to prescribe. This was a systematic, top-down, active deception.

While Dr. Van Zee was fighting alone in the Appalachian mountains, he didn't know that his efforts had ignited another front. In the Western District of Virginia, two Assistant U.S. Attorneys, Randy Ramseyer and Rick Mountcastle, began to notice these coincidences. Ramseyer, a steady former Marine, found that almost all bank robberies and violent crimes he prosecuted eventually pointed to the same thing—OxyContin. They decided not to just arrest addicts; they would follow the trail all the way up to the source.

Meanwhile, in Washington, Laura Nagel, the new director of the DEA's Diversion Control Office, was also enraged. Nagel was a tough agent, tired of Purdue's PR rhetoric. She and her team began openly challenging Purdue's official narrative. In 2001, Nagel had a showdown with Purdue executives. Nagel stated directly, "This is out of control," and suggested Purdue restrict prescribing privileges or pharmacies. Purdue's chief counsel, Udell, merely understated, "We'll consider that suggestion." Days later, Nagel received a five-page letter from CEO Friedman. It was an arrogant letter. In it, Friedman refuted media reports of death tolls point by point, claiming that 59 deaths in Kentucky could not be confirmed, and that 35 deaths in Maine were actually only 12. After reading the letter, Nagel told her colleague, "This is a 'fuck you' letter."

Purdue even deployed their political weapons. They hired Rudy Giuliani, the post-9/11 mayor of New York. Giuliani used his connections to bypass Nagel and met directly with Asa Hutchinson, the highest official at the DEA. Soon, the internal DEA investigation into Purdue's manufacturing facilities mysteriously slowed down.

But Purdue underestimated the determination of the two federal prosecutors in Abingdon. Ramseyer and Mountcastle did not back down; they convened a grand jury and began a four-year secret investigation. They subpoenaed former Purdue sales representatives, managers, doctors, pharmacists, and even Maureen Sara, a female employee previously silenced by Udell. They obtained the 1999 training memos and internal emails regarding internet abuse. The investigation concluded in 2006, and prosecutors drafted a 120-page indictment memo. Their conclusion was that Purdue Pharma had committed felonies. They recommended indicting CEO Friedman, lawyer Udell, and Chief Medical Officer Gordon Heim on felony charges such as "conspiracy to defraud the United States."

This time, the sword hung over the empire's head; this was the moment when the Sackler family's proxies should have been sent to prison. But at the last minute, politics intervened again. Purdue hired Washington's top legal team. They began to pressure high-ranking officials at the Department of Justice in Washington. Their argument was that prosecuting executives would set a dangerous precedent, putting all pharmaceutical company executives at risk, and that it would be a long, expensive, and not necessarily winnable trial. High-ranking officials at the Department of Justice in Washington backed down. They rejected Ramseyer and Mountcastle's felony indictment recommendations and forced the Virginia team to accept a compromise—a plea agreement.

This is what happened on May 10, 2007. What should have been a day of truth became a carefully orchestrated legal performance. This was the deal: 1. **Purdue Pharma admitted to a misdemeanor**: "Misbranding," acknowledging its intent to defraud or mislead the public. 2. **Three executives**: Friedman, Udell, and Gordon Heim, admitted no individual wrongdoing but pleaded guilty to a "misdemeanor under strict liability," meaning that as responsible executives of the company, they were liable for the company's illegal actions, even if they were unaware.

You see, this is the art of language. They spent four years proving that these three individuals knew about and participated in the deception, but the final legal documents allowed them to claim ignorance. What was the outcome? The company was fined $634.5 million. The three executives did not spend a single day in prison; they were sentenced to community service. For a company with billions in annual sales and tens of billions in cumulative profits at the time, this fine was not even a minor setback; it was merely a cost of doing business.

But something more important than legal statutes happened in court that day. The judge allowed victims' families to speak. Parents from across the country stood up, holding photos of their children (mostly teenagers), looking directly at the three expressionless executives. One mother said, "I hope you are haunted by my son's face until the day you die." One father said, "The only difference between you and the drug dealers peddling drugs on the street is that you wear suits and ties."

When it was prosecutor Randy Ramseyer's turn to speak, he abandoned diplomatic language. He knew justice had miscarried, and he decided to leave the truth on the court record. He said to the judge, "How wonderful it would be if the company's lawyers could step up and say Purdue is sorry for the crimes it committed, and then sit down. How wonderful it would be if these executives' lawyers could step up and say they are sorry, they betrayed the public's trust, and then sit down. But we all know that won't happen."

Ramseyer predicted: "When I sit down, Purdue Pharma's next PR campaign will immediately begin; they will try to minimize the crimes they committed." Ramseyer's prophecy came true. Udell's lawyer immediately stood up and delivered a speech that could only be described as shameless. He completely ignored the prosecutor's anger and began a PR performance. He did not apologize; instead, he began to boast about how leading Purdue was in pain management, how they "voluntarily" took action, and how they were committed to balancing patient needs with abuse risks.

In the back of the courtroom sat Dr. Art Van Zee, the rural doctor from Lee County, and the tenacious Sister Beth Davies. They had driven for hours to be there, just to witness this scene. Sister Davies later said, "We didn't get what we wanted, but at least they didn't get away with it completely."

In 2007, the trial ended. Purdue paid the fine, and the executives returned to their mansions in Connecticut. Not a single member of the Sackler family even appeared in court. For them, it seemed like merely a minor setback. But what they didn't know was that the evidence collected by Ramseyer and Mountcastle—the 120-page indictment memo and thousands of internal emails sealed by the Department of Justice—would one day see the light of day. And that was the significance of investigative journalist Barry Meier writing his book, "Pain Killer."

Alright, with the story told, we need to step back and deeply analyze how the OxyContin empire of pain was built. It wasn't just the greed of one company; it was the product of a systemic, multi-party conspiracy. This empire was built on three seemingly indestructible pillars:

**The first pillar: Sackler's original sin of marketing.** We must understand that Purdue Pharma's crime was not negligence, but intentional. Arthur Sackler's philosophy was: medicine can be marketed, and demand can be created. They precisely executed this tactic: * **Corruption of language**: "Pseudoaddiction" turned danger signals into buying signals; "less than 1%" turned lies into science. * **Manipulation of emotion**: They exploited doctors' good intentions of not wanting patients to suffer, weaponizing this goodwill into moral blackmail to push their powerful narcotics. * **Binding of interests**: Through luxury travel, speaking fees, and research grants, they co-opted the entire academic community in pain management, getting the most influential doctors to endorse them.

**The second pillar: The regulatory revolving door.** The FDA should have been the people's watchdog, but in this story, it became an accomplice. Curtis Wright, the official who approved the miraculous "reduced abuse potential" label, turned around and joined Purdue, earning nearly $400,000 a year. This revolving door sent a clear signal: if you cooperate with corporations, you will be rewarded. When Laura Nagel's DEA tried to issue a warning, the FDA's first reaction was not cooperation, but maintaining stability, refuting DEA's data as unscientific, and reassuring the public not to panic. They were protecting the drugs they had approved, not the public.

**The third pillar: Bought science.** This is the most chilling. We trust doctors because we believe in the scientific spirit behind them. But the story of OxyContin tells us that science can be customized. Remember the "less than 1%" myth? It came from a five-sentence letter to the editor in 1980; it was not rigorous research at all. And true experts, like Russell Portenoy, lost their way in this pharmaceutical-funded revolution. They were well-intentioned evangelists, and to spread the gospel of pain relief, they exaggerated efficacy and ignored risks. When the line between science and marketing is blurred by money, the public is always the victim.

These three pillars combined to form a perfect closed loop: a company used its self-created "science," bought off a group of experts, convinced lax regulators, and ultimately turned a lie into standard practice for doctors across America.

The 2007 fine did not shake the empire's foundations at all. The 2007 trial was not the end of the story; on the contrary, it was the beginning of another hell. To cope with lawsuits and regulations, Purdue Pharma finally launched the new crush-resistant OxyContin formula in 2010—exactly what Dr. Van Zee had pleaded with them to do 10 years earlier. It was too late. By 2010, Purdue had cultivated millions of opioid addicts in the United States. When these people suddenly found they could no longer get a high from OxyContin, what would they do? Did they quit? No, they turned to cheaper, more readily available alternatives—heroin. And when drug dealers found heroin wasn't strong enough, they started mixing in even more potent synthetic opioids—fentanyl. Purdue Pharma ignited this fire, and fentanyl was the gasoline poured on it. This man-made plague continues to rage today.

What does this story leave us with? It tells us that good intentions can be exploited. The noble goal of relieving patients' pain was twisted into indiscriminate prescribing for commercial gain. It tells us that regulation is fragile, how easily regulatory bodies can fail in the face of powerful political lobbying and the allure of the revolving door. It also tells us that truth needs to be defended. Without people like Art Van Zee, Beth Davies, Laura Nagel, and those two tenacious prosecutors, Randy Ramseyer and Rick Mountcastle—without their persistence in fighting this billion-dollar empire—we would never even know about those 1999 internal memos regarding snorting and street value.

In 2015, Forbes magazine ranked the Sackler family as the 16th wealthiest family in America, with assets of $14 billion. To this day, when you walk into those great museums, you can still see their family name. But now, when you know the story behind this wealth, what will you see when you look at those exquisite works of art?